Firefighters warn about carbon monoxide hazard

Firefighters on Thursday were cautioning about carbon monoxide poisoning, saying this is the time of year the unseen hazard tends to catch people by surprise.

CVS is trying out pharmacists in chronic health management

Dr. Amy Compton-Phillips on Friday said healthcare affordability and access could ​potentially improve if pharmacists in its 9,000 retail stores play a bigger role in chronic disease management.

Swiss drug developer Windward Bio files for US IPO

Windward Bio filed for a US initial public ​offering on Friday, becoming the latest drug developer seeking to capitalize on renewed investor ‌interest in biotech listings.

US CDC says measles cases rise to 4,588 as outbreak continues

The US CDC on Friday reported ​4,588 measles cases in the country as of October 22, up 178 ‌from a week earlier, as an outbreak of ⁠the highly contagious ​disease continues.

UK approves J&J's oral psoriasis pill

Britain's medicines regulator on Friday approved Johnson & Johnson's ​daily pill for adults and teenagers with moderate-to-severe plaque psoriasis, a skin condition ‌causing red, scaly and often itchy or painful patches.

Dr Reddy's beats quarterly profit estimate on India market lift

Indian drugmaker Dr Reddy's Laboratories reported a better-than-expected quarterly profit on Friday, as domestic ​demand helped cushion the slowdown in its key US market.

Bristol Myers, SystImmune breast cancer drug cuts progression risk in study

Bristol Myers Squibb and partner SystImmune said on Friday their experimental ​breast cancer treatment slowed disease progression compared to standard chemotherapy in a late-stage study.

Zymeworks licenses experimental lung cancer drug to Roche in up to $813 million deal

Zymeworks said on Friday Roche has ​gained rights to develop and commercialize its experimental lung cancer drug under ‌a global licensing deal worth up to $813 million.

Exclusive-Dr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit

Dr Reddy's Laboratories has expanded its portfolio of generic versions of Ozempic with two new brands to fill a supply-chain hit to ​its original Obeda injections, product photographs and marketing materials reviewed by Reuters show.

Weight-loss drugs fuel protein boom, but with more consumer scrutiny

Protein-infused bottled water. Ice cream. Boxed macaroni and cheese. Even vodka.